Trium Capital’s Augmedix AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-1,182,119
Closed -$2.78M – 71
2024
Q3
$2.78M Buy
+1,182,119
New +$2.39M 0.79% 25

Trium Capital's AUGX Position: Q4 2024 in Review

Trium Capital sold out of Augmedix (AUGX) in Q4 2024, closing a stake of 1,182,119 shares — an estimated $2.78M sold.

Trium Capital first reported a position in AUGX in Q3 2024 and held it in 1 quarter. The position peaked at $2.78M in Q3 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Trium Capital reported no remaining Augmedix position as of Q4 2024 after selling out during the quarter.
  • Trium Capital sold 1,182,119 Augmedix shares in Q4 2024, an estimated $2.78M.
  • Trium Capital first reported a position in Augmedix in Q3 2024 and held it in 1 quarter.
  • Trium Capital's Augmedix position peaked at $2.78M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Augmedix as of Q4 2024.

Based on Trium Capital's 13F filing for Q4 2024, filed 15 Jan 2025.